,i #aahth ,,congress #ast ,session ,h4 ,r4 #acc ,,in ,,the ,,house ,,of ,,representatives ,january #i1 #bjbc,mr4 ,buchanan 7for himself1 ,ms4 ,barragn1 and ,ms4 ,salazar7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xviii of the ,social ,security ,act to clarify the use of the national coverage determination process under the ,medicare program4 #a4 ,short title ,this ,act may be cited as the ,mandating ,exclusive ,review of ,individual ,treatments 7,,merit7 ,act4 #b4 ,clarification on ,medicare national coverage determination process ,section #ahfb7;a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciey7a77 is amended by adding at the end the following new sentence3 ,for purposes of paragraph 7#a77;,e71 in the case of research conducted pursuant to section #aadb1 the determination of whether a drug or biological is reasonable and necessary to carry out the purposes of section #aadb shall be made with respect to each drug or biological involved and not with respect to a class of drugs or biologicals44